New Products


The latest in medical products for obstetrics and gynecology.

Fewer false negatives is goal of newly cleared Pap test

The goal of more comprehensive cell specimen collection is to cut the rate of false negatives, leading to earlier cervical cancer treatment, CytoCore says, adding that there's less trauma to the cervix and less bleeding and spotting than with traditional methods.

The FDA approves Avastin for metastatic HER2-negative breast ca

The FDA has granted accelerated approval to Genentech's targeted biological agent Avastin (bevacizumab)-already approved for colorectal and lung cancers in combination with chemotherapy-for first-line therapy of metastatic HER2-negative breast cancer, when used in conjunction with paclitaxel. The approval was based on progression-free survival, a less stringent criterion than the increased overall survival benefit that's required for non-life threatening diseases.

In 2006, the FDA had turned down the company in its previous try for approval of this indication. The decision this time was based on a clinical trial in which patients who received Avastin along with paclitaxel experienced no worsening of their cancer for a median of 11.3 months (vs. 5.8 months for those receiving paclitaxel alone). And although the Avastin group survived a median of 26.5 months-1.7 months longer than the paclitaxel-alone women-results were not statistically significant.

For more information, visit

Only FDA-cleared home detection test for leaking amniotic fluid

Although pH levels of 5.2 or greater will produce a blue-green color that stays stable for at least a week (unlike fluids such as urine, which reverse color changes within 30 minutes), home-users are told to report all positive or negative results to you for interpretation.

For more information about the kit, which wholesales for $46.88, call 1-877-Amni-Kit (1-877-266-4548) or visit the company's Web site at, where you can download a brochure.

Related Videos
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:
Enhancing cervical cancer management with dual stain | Image Credit:
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit:
Understanding the impact of STIs on young adults | Image Credit:
CDC estimates of maternal mortality found overestimated | Image Credit:
Study unveils maternal mortality tracking trends | Image Credit:
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit:
Unveiling gender disparities in medicine | Image Credit:
Exploring the intersection of heart health and women's health | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.